Bedsores can cause pain and limit the function of people who spend significant time in bed and struggle to change positions.
People who live in long-term care facilities, including elders and individuals with disabilities, often experience bedsores. Fortunately, promising new treatments, such as recombinant human EGF, may help heal bedsores and other wounds.
Bedsores and treatment
Bedsores are a type of pressure ulcer that affects the skin and tissue below. Medical conditions that prevent people from moving and require bedrest can cause bedsores. Wheelchair users can develop pressure ulcers as well. Bedsores can develop over a few days. These injuries often appear on bony areas, including hips, ankles and shoulders. Affected areas may appear swollen or tender before developing into an ulcer.
Recombinant Human EGF
Changing positions can help prevent and alleviate bedsores. In addition, there are topical skin treatments that help bedsores heal more efficiently. For example, recombinant human EGF is a protein substance containing growth factors that encourage the development of new skin cells. Recombinant human EGF may help treat wounds that are difficult to heal, such as scalds, diabetic ulcers and bedsores. This treatment could benefit people in long-term care facilities who have medical conditions that make movement more difficult. Furthermore, better treatments for bedsores can aid people who are on bedrest and people who use wheelchairs.
The pain of bedsores harms people with chronic conditions and disabilities as well as older adults in long-term care. Recombinant human EDF treatments can improve the healing process for individuals with bedsores.